Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5935)
All Articles published online
|
Sep 7, 2008 (publication date) through Nov 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Qin TJ, Zhao XH, Yun J, Zhang LX, Ruan ZP, Pan BR. Efficacy and safety of gemcitabine-oxaliplatin combined with huachansu in patients with advanced gallbladder carcinoma. World J Gastroenterol 2008; 14(33): 5210-5216 [PMID: 18777599 DOI: 10.3748/wjg.14.5210] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i33/5210.htm |
| Number | Citing Articles |
| 1 |
Munehiro Nakata, Shota Kawaguchi, Ayami Oikawa, Akito Inamura, Shunki Nomoto, Hirokazu Miyai, Tomomi Nonaka, Saeko Ichimi, Yoko Fujita-Yamaguchi, Chuan Luo, Bo Gao, Wei Tang. An aqueous extract from toad skin prevents gelatinase activities derived from fetal serum albumin and serum-free culture medium of human breast carcinoma MDA-MB-231 cells. Drug Discoveries & Therapeutics 2015; 9(6): 417 doi: 10.5582/ddt.2015.01060
|
| 2 |
Trapti Aggarwal, Akhilesh K. Verma. Protecting‐Group‐Free Organic Synthesis. 2018; : 133 doi: 10.1002/9781119295266.ch5
|
| 3 |
Qi Wu, Shao-Ping Wang, Xiao-Xue Sun, Yu-Fan Tao, Xiao-Qing Yuan, Qi-Mei Chen, Long Dai, Chun-Lei Li, Jia-Yu Zhang, Ai-Lin Yang. HuaChanSu suppresses tumor growth and interferes with glucose metabolism in hepatocellular carcinoma cells by restraining Hexokinase-2. The International Journal of Biochemistry & Cell Biology 2022; 142: 106123 doi: 10.1016/j.biocel.2021.106123
|
| 4 |
Rui-Fang Xie, Zhi-Cheng Li, Pei-Pei Chen, Xin Zhou. Bufothionine induced the mitochondria-mediated apoptosis in H22 liver tumor and acute liver injury. Chinese Medicine 2015; 10(1) doi: 10.1186/s13020-015-0033-1
|
| 5 |
Masami Ichikawa, Yoshihiro Sowa, Yosuke Iizumi, Yuichi Aono, Toshiyuki Sakai, Sumitra Deb. Resibufogenin Induces G1-Phase Arrest through the Proteasomal Degradation of Cyclin D1 in Human Malignant Tumor Cells. PLOS ONE 2015; 10(6): e0129851 doi: 10.1371/journal.pone.0129851
|
| 6 |
Neha Yadav, Rohitas Deshmukh, Rupa Mazumder. A comprehensive review on the use of traditional Chinese medicine for cancer treatment. Pharmacological Research - Modern Chinese Medicine 2024; 11: 100423 doi: 10.1016/j.prmcm.2024.100423
|
| 7 |
F. Meriggi, A. Zaniboni. Gemox: A Widely Useful Therapy Against Solid Tumors-Review and Personal Experience. Journal of Chemotherapy 2010; 22(5): 298 doi: 10.1179/joc.2010.22.5.298
|
| 8 |
Yafeng Sun, Xianhong Zhang. RETRACTED: Bufothionine Promotes Apoptosis via Triggering ER Stress and Synergizes with Temozolomide in Glioblastoma Multiforme Cells. The Anatomical Record 2019; 302(11): 1950 doi: 10.1002/ar.24194
|
| 9 |
Bo Yuan, Jingmei Li, Shin-Ich Miyashita, Hidetomo Kikuchi, Meiyan Xuan, Hirokazu Matsuzaki, Naohiro Iwata, Shinya Kamiuchi, Katsuyoshi Sunaga, Takeshi Sakamoto, Yasuhide Hibino, Mari Okazaki. Enhanced Cytotoxic Effects of Arenite in Combination with Active Bufadienolide Compounds against Human Glioblastoma Cell Line U-87. Molecules 2022; 27(19): 6577 doi: 10.3390/molecules27196577
|
| 10 |
Jinglin Zou, Cong Jiang, Xianglong Li, Tianyu Zhong, Shuqi Wang, Bo Wang, Dapeng Zhang, Ji-Na Hao, Yuanyuan Cao, Mengjia Guan, Peng Zhang, Bin Dai, Yongsheng Li. Redox-responsive engineered hybrid nanomedicine for gallbladder cancer therapy via hyaluronic acid depletion. Applied Materials Today 2023; 30: 101707 doi: 10.1016/j.apmt.2022.101707
|
| 11 |
Linxuan Miao, Ying Liu, Nasra Mohamoud Ali, Yan Dong, Bin Zhang, Xiaonan Cui. Bufalin serves as a pharmaceutic that mitigates drug resistance. Drug Metabolism Reviews 2023; 55(3): 195 doi: 10.1080/03602532.2023.2206065
|
| 12 |
Jie Wang, Han Cai, Qiaoli Liu, Yue Xia, LiKai Xing, Qingsong Zuo, Yong Zhang, Cao Chen, Ke Xu, Peihao Yin, Teng Chen. Cinobufacini Inhibits Colon Cancer Invasion and Metastasis via Suppressing Wnt/β-Catenin Signaling Pathway and EMT. The American Journal of Chinese Medicine 2020; 48(03): 703 doi: 10.1142/S0192415X20500354
|
| 13 |
Guojun Wang, Guanghui Liu, Yanwei Ye, Yang Fu, Xiefu Zhang. Bufothionine exerts anti-cancer activities in gastric cancer through Pim3. Life Sciences 2019; 232: 116615 doi: 10.1016/j.lfs.2019.116615
|
| 14 |
Elisa Correa Fornari Baldo, Fernando Antonio Pino Anjolette, Eliane Candiani Arantes, Mateus Amaral Baldo. Toxins and Drug Discovery. 2015; : 1 doi: 10.1007/978-94-007-6726-3_16-1
|
| 15 |
Mohammad Ali, Shahid Ud Din Wani, Md Salahuddin, Manjula S.N., Mruthunjaya K, Tathagata Dey, Mohammed Iqbal Zargar, Jagadeesh Singh. Recent advance of herbal medicines in cancer- a molecular approach. Heliyon 2023; 9(2): e13684 doi: 10.1016/j.heliyon.2023.e13684
|
| 16 |
Chun Li, Saeed M. Hashimi, Siyu Cao, Albert S. Mellick, Wei Duan, David Good, Ming Q. Wei. The Mechanisms of Chansu in Inducing Efficient Apoptosis in Colon Cancer Cells. Evidence-Based Complementary and Alternative Medicine 2013; 2013: 1 doi: 10.1155/2013/849054
|
| 17 |
Kaili Wang, Danxia Chu, Jie Wu, Mengling Zhao, Miaomiao Zhang, Bijun Li, Wenjun Du, Jianmin Du, Ruixia Guo. WITHDRAWN: Cinobufagin induced cell apoptosis and protective autophagy through the ROS/MAPK signaling pathway. Life Sciences 2019; : 116642 doi: 10.1016/j.lfs.2019.116642
|
| 18 |
Bo Yuan, Jing He, Keishi Kisoh, Hideki Hayashi, Sachiko Tanaka, Nan Si, Hai-Yu Zhao, Toshihiko Hirano, Baolin Bian, Norio Takagi. Effects of active bufadienolide compounds on human cancer cells and CD4+CD25+Foxp3+ regulatory T cells in mitogen-activated human peripheral blood mononuclear cells. Oncology Reports 2016; 36(3): 1377 doi: 10.3892/or.2016.4946
|
| 19 |
Cameron T. Durlacher, Kevin Chow, Xiao‐Wu Chen, Zhi‐Xu He, Xueji Zhang, Tianxin Yang, Shu‐Feng Zhou. Targeting Na+/K+‐translocating adenosine triphosphatase in cancer treatment. Clinical and Experimental Pharmacology and Physiology 2015; 42(5): 427 doi: 10.1111/1440-1681.12385
|
| 20 |
Kevin Yi-Lwern Yap, Ken Juin Lim. Merging the old with the new: a cybermedicine marriage for oncology interactions with traditional herbal therapies and complementary medicines. TANG [HUMANITAS MEDICINE] 2012; 2(2): 18.1 doi: 10.5667/tang.2012.0004
|
| 21 |
Jiao CHEN, Dan LIN, Jie YANG, XueTing CAI, GuoLi WEI, Peng CAO. Advances in the synergistic and toxic attenuating effect of traditional Chinese medicine in cancer treatment. SCIENTIA SINICA Vitae 2022; 52(6): 920 doi: 10.1360/SSV-2021-0389
|
| 22 |
Wan Najbah Nik Nabil, Rongchen Dai, Mengfan Liu, Zhichao Xi, Hongxi Xu. Repurposing cardiac glycosides for anticancer treatment: a review of clinical studies. Drug Discovery Today 2024; 29(10): 104129 doi: 10.1016/j.drudis.2024.104129
|
| 23 |
Lu Kong, Xu Liu, Bing Yu, Ye Yuan, Qianru Zhao, Yuru Chen, Bin Qu, Xue Du, Xiaoxuan Tian, Rui Shao, Yu Wang. Cinobufacini Injection Inhibits the Proliferation of Triple-Negative Breast Cancer Through the Pin1–TAZ Signaling Pathway. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.797873
|
| 24 |
Munehiro Nakata, Shuya Mori, Yo Kamoshida, Shota Kawaguchi, Yoko Fujita-Yamaguchi, Bo Gao, Wei Tang. Toad skin extract cinobufatini inhibits migration of human breast carcinoma MDA-MB-231 cells into a model stromal tissue. BioScience Trends 2015; 9(4): 266 doi: 10.5582/bst.2015.01109
|
| 25 |
Qian Li, Chuanwu Jiang, Yan Wang, Minghua Wei, Huijin Zheng, Yanqi Xu, Xuegang Xu, Fengyu Jia, Kai Liu, Gang Sun, Jianhua Zang, Ping Mo. RETRACTED ARTICLE: Resibufogenin suppresses tumor growth and inhibits glycolysis in ovarian cancer by modulating PIM1. Naunyn-Schmiedeberg's Archives of Pharmacology 2019; 392(12): 1477 doi: 10.1007/s00210-019-01687-2
|
| 26 |
Shu-Yi Yin, Wen-Chi Wei, Feng-Yin Jian, Ning-Sun Yang. Therapeutic Applications of Herbal Medicines for Cancer Patients. Evidence-Based Complementary and Alternative Medicine 2013; 2013: 1 doi: 10.1155/2013/302426
|
| 27 |
Elisa Correa Fornari Baldo, Fernando Antonio Pino Anjolette, Eliane Candiani Arantes, Mateus Amaral Baldo. Toxins and Drug Discovery. Toxinology 2017; : 373 doi: 10.1007/978-94-007-6452-1_16
|
| 28 |
Fanghua Qi, Anyuan Li, Lin Zhao, Huanli Xu, Yoshinori Inagaki, Dongliang Wang, Xiaoyan Cui, Bo Gao, Norihiro Kokudo, Munehiro Nakata, Wei Tang. Cinobufacini, an aqueous extract from Bufo bufo gargarizans Cantor, induces apoptosis through a mitochondria-mediated pathway in human hepatocellular carcinoma cells. Journal of Ethnopharmacology 2010; 128(3): 654 doi: 10.1016/j.jep.2010.02.022
|
| 29 |
Bo Yuan, Kang Xu, Ryota Shimada, JingZhe Li, Hideki Hayashi, Mari Okazaki, Norio Takagi. Cytotoxic Effects of Arsenite in Combination With Gamabufotalin Against Human Glioblastoma Cell Lines. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.628914
|
| 30 |
Emma K. Davison, Jonathan Sperry. Alkaloids from the traditional chinese medicine ChanSu: synthesis-enabled structural reassignment of bufopyramide to bufoserotonin C. Organic & Biomolecular Chemistry 2015; 13(29): 7911 doi: 10.1039/C5OB01051A
|
| 31 |
Yili Shen, Haijian Cai, Shenjie Ma, Wenjing Zhu, Haiyang Zhao, Jifa Li, Hua Ye, Lehe Yang, Chengguang Zhao, Xiaoying Huang, Zhongxiao Xiao. Telocinobufagin Has Antitumor Effects in Non-Small-Cell Lung Cancer by Inhibiting STAT3 Signaling. Journal of Natural Products 2022; 85(4): 765 doi: 10.1021/acs.jnatprod.1c00761
|
| 32 |
LIN YE, YONGNING JIA, KE JI, ANDREW J. SANDERS, KAN XUE, JIAFU JI, MALCOLM D. MASON, WEN G. JIANG. Traditional Chinese medicine in the prevention and treatment of cancer and cancer metastasis. Oncology Letters 2015; 10(3): 1240 doi: 10.3892/ol.2015.3459
|
| 33 |
Ailin Yang, Qi Wu, Qimei Chen, Jingyi Yang, Haoran Li, Yufan Tao, Anmei Wang, Yaxue Sun, Jiayu Zhang. Cinobufagin restrains the growth and triggers DNA damage of human hepatocellular carcinoma cells via proteasome-dependent degradation of thymidylate synthase. Chemico-Biological Interactions 2022; 360: 109938 doi: 10.1016/j.cbi.2022.109938
|
| 34 |
Xu Wu, Haiyu Zhao, Hongjie Wang, Bo Gao, Jian Yang, Nan Si, Baolin Bian. Simultaneous determination of eight bufadienolides in cinobufacini injection by HPLC coupled with triple quadrupole mass spectrometry. Journal of Separation Science 2012; 35(15): 1893 doi: 10.1002/jssc.201200036
|
| 35 |
Yingbo Zhang, Xiaomin Tang, Yuxin Pang, Luqi Huang, Dan Wang, Chao Yuan, Xuan Hu, Liping Qu. The Potential Mechanism of Bufadienolide-Like Chemicals on Breast Cancer via Bioinformatics Analysis. Cancers 2019; 11(1): 91 doi: 10.3390/cancers11010091
|
| 36 |
Xia Liu, Xiang-yang Xiao, Qi-yang Shou, Jun-feng Yan, Long Chen, Hui-ying Fu, Jian-chao Wang. Bufalin inhibits pancreatic cancer by inducing cell cycle arrest via the c-Myc/NF-κB pathway. Journal of Ethnopharmacology 2016; 193: 538 doi: 10.1016/j.jep.2016.09.047
|
| 37 |
Mohammad Taghizadieh, Motahareh Seyedi, Sara Azhdari, Fatemeh Dashti, Sayad Mohammad Ali Mirazimi, Hossein Bannazadeh Baghi, Javid Sadri Nahand, Michael Aschner, Hamed Mirzaei. Gallbladder Cancer. 2023; : 3 doi: 10.1007/978-981-19-6442-8_1
|
| 38 |
Yitao Gong, Zhiyao Fan, Guopei Luo, Chao Yang, Qiuyi Huang, Kun Fan, He Cheng, Kaizhou Jin, Quanxing Ni, Xianjun Yu, Chen Liu. The role of necroptosis in cancer biology and therapy. Molecular Cancer 2019; 18(1) doi: 10.1186/s12943-019-1029-8
|
| 39 |
Lina Ma, Bing Song, Hua Jin, Jiang Pi, Li Liu, Jinhuan Jiang, Jiye Cai. Cinobufacini induced MDA-MB-231 cell apoptosis-associated cell cycle arrest and cytoskeleton function. Bioorganic & Medicinal Chemistry Letters 2012; 22(3): 1459 doi: 10.1016/j.bmcl.2011.11.095
|
| 40 |
Xiaoling Song, Yunping Hu, Yongsheng Li, Rong Shao, Fatao Liu, Yingbin Liu. Overview of current targeted therapy in gallbladder cancer. Signal Transduction and Targeted Therapy 2020; 5(1) doi: 10.1038/s41392-020-00324-2
|
| 41 |
Yinfang Xu, Xuan Liu, Silvia Schwarz, Lihong Hu, Dean Guo, Quanbao Gu, Wolfgang Schwarz. Inhibitory efficacy of bufadienolides on Na + ,K + -pump activity versus cell proliferation. Biochemistry and Biophysics Reports 2016; 6: 158 doi: 10.1016/j.bbrep.2016.03.015
|
| 42 |
Bo-Bo Zheng, Quan Wang, Yumin Yue, Jiang Li, Xiao-Jun Li, Xin Wang, Syed Sameer Aga. Network Pharmacology and Molecular Docking Validation to Reveal the Pharmacological Mechanisms of Kangai Injection against Colorectal Cancer. BioMed Research International 2022; 2022: 1 doi: 10.1155/2022/3008842
|
| 43 |
Chun Li, Saeed M. Hashimi, Siyu Cao, Ji Qi, David Good, Wei Duan, Ming Q. Wei. Chansu inhibits the expression of cortactin in colon cancer cell lines in vitro and in vivo. BMC Complementary and Alternative Medicine 2015; 15(1) doi: 10.1186/s12906-015-0723-3
|
| 44 |
Li-Juan Deng, Yong Li, Ming Qi, Jun-Shan Liu, Sheng Wang, Li-Jun Hu, Yu-He Lei, Ren-Wang Jiang, Wei-Min Chen, Qi Qi, Hai-Yan Tian, Wei-Li Han, Bao-Jian Wu, Jia-Xu Chen, Wen-Cai Ye, Dong-Mei Zhang. Molecular mechanisms of bufadienolides and their novel strategies for cancer treatment. European Journal of Pharmacology 2020; 887: 173379 doi: 10.1016/j.ejphar.2020.173379
|
| 45 |
Fanghua Qi, Anyuan Li, Yoshinori Inagaki, Norihiro Kokudo, Sumihito Tamura, Munehiro Nakata, Wei Tang. Antitumor activity of extracts and compounds from the skin of the toad Bufo bufo gargarizans Cantor. International Immunopharmacology 2011; 11(3): 342 doi: 10.1016/j.intimp.2010.12.007
|
| 46 |
Jingnan Xu, Zhuo Song, Qiujun Guo, Jie Li. Synergistic Effect and Molecular Mechanisms of Traditional Chinese Medicine on Regulating Tumor Microenvironment and Cancer Cells. BioMed Research International 2016; 2016: 1 doi: 10.1155/2016/1490738
|
| 47 |
Dong-yan Chen, Rui Zhang, Ying Liu, Tao Zhou, Xiang Li, Shan Gao, Jian Zhang, Xiao-nan Cui. Effects of cinobufacini injection on hepatocarcinoma cell proliferation, invasion and metastasis. RSC Advances 2016; 6(85): 82417 doi: 10.1039/C6RA08923B
|
| 48 |
Jinnong Li, Zhenhua Liu, Ruiqi Chen, Dan Hu, Wenjuan Li, Xiajing Li, Xuzheng Chen, Baokang Huang, Lianming Liao. The quality of reports of randomized clinical trials on traditional Chinese medicine treatments: a systematic review of articles indexed in the China National Knowledge Infrastructure database from 2005 to 2012. BMC Complementary and Alternative Medicine 2014; 14(1) doi: 10.1186/1472-6882-14-362
|
| 49 |
Lingyu Han, Bo Yuan, Ryota Shimada, Hideki Hayashi, Nan Si, Hai-Yu Zhao, Baolin Bian, Norio Takagi. Cytocidal effects of arenobufagin and hellebrigenin, two active bufadienolide compounds, against human glioblastoma cell line U-87. International Journal of Oncology 2018; doi: 10.3892/ijo.2018.4567
|
| 50 |
Guangxin Zhang, Chao Wang, Mei Sun, Jindong Li, Bin Wang, Chengyan Jin, Peiyan Hua, Ge Song, Yifan Zhang, Lisa L.H. Nguyen, Ranji Cui, Runhua Liu, Lizhong Wang, Xingyi Zhang. Cinobufagin inhibits tumor growth by inducing intrinsic apoptosis through AKT signaling pathway in human nonsmall cell lung cancer cells. Oncotarget 2016; 7(20): 28935 doi: 10.18632/oncotarget.7898
|
| 51 |
Karla de Castro Figueiredo Bordon, Camila Takeno Cologna, Elisa Corrêa Fornari-Baldo, Ernesto Lopes Pinheiro-Júnior, Felipe Augusto Cerni, Fernanda Gobbi Amorim, Fernando Antonio Pino Anjolette, Francielle Almeida Cordeiro, Gisele Adriano Wiezel, Iara Aimê Cardoso, Isabela Gobbo Ferreira, Isadora Sousa de Oliveira, Johara Boldrini-França, Manuela Berto Pucca, Mateus Amaral Baldo, Eliane Candiani Arantes. From Animal Poisons and Venoms to Medicines: Achievements, Challenges and Perspectives in Drug Discovery. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.01132
|
| 52 |
Qing Wu, Wei-Dong Lin, Guan-Qun Liao, Li-Guo Zhang, Shun-Qian Wen, Jia-Ying Lin. Antiproliferative effects of cinobufacini on human hepatocellular carcinoma HepG2 cells detected by atomic force microscopy. World Journal of Gastroenterology 2015; 21(3): 854-861 doi: 10.3748/wjg.v21.i3.854
|
| 53 |
Yue Hao, Xinxin Luo, Xiyuan Ba, Jiali Wang, Shiyang Zhou, Shimin Yang, Changji Fang, Changyu Jiang, Wuping Sun. Huachansu suppresses TRPV1 up-regulation and spinal astrocyte activation to prevent oxaliplatin-induced peripheral neuropathic pain in rats. Gene 2019; 680: 43 doi: 10.1016/j.gene.2018.09.035
|
| 54 |
Dong-Ze Qiu, Zhou-Ji Zhang, Wei-Zhong Wu, Yun-Ke Yang. Bufalin, a component in Chansu, inhibits proliferation and invasion of hepatocellular carcinoma cells. BMC Complementary and Alternative Medicine 2013; 13(1) doi: 10.1186/1472-6882-13-185
|
| 55 |
Bo Yuan, Ryota Shimada, Kang Xu, Lingyu Han, Nan Si, Haiyu Zhao, Baolin Bian, Hideki Hayashi, Mari Okazaki, Norio Takagi. Multiple cytotoxic effects of gamabufotalin against human glioblastoma cell line U-87. Chemico-Biological Interactions 2019; 314: 108849 doi: 10.1016/j.cbi.2019.108849
|
| 56 |
Fanghua Qi, Lin Zhao, Aiyan Zhou, Bo Zhang, Anyuan Li, Zhixue Wang, Junqing Han. The advantages of using traditional Chinese medicine as an adjunctive therapy in the whole course of cancer treatment instead of only terminal stage of cancer. BioScience Trends 2015; 9(1): 16 doi: 10.5582/bst.2015.01019
|
| 57 |
Konstantinos Alevizopoulos, Konstantinos Dimas, Natalia Papadopoulou, Eva-Maria Schmidt, Anna Tsapara, Saad Alkahtani, Sabina Honisch, Kyriakos C. Prousis, Saud Alarifi, Theodora Calogeropoulou, Florian Lang, Christos Stournaras. Functional characterization and anti-cancer action of the clinical phase II cardiac Na+/K+ ATPase inhibitor istaroxime: in vitro and in vivo properties and cross talk with the membrane androgen receptor. Oncotarget 2016; 7(17): 24415 doi: 10.18632/oncotarget.8329
|
| 58 |
Jihan Huang, Feiyu Chen, Zhangfeng Zhong, Hor Yue Tan, Ning Wang, Yuting Liu, Xinyuan Fang, Tao Yang, Yibin Feng. Interpreting the Pharmacological Mechanisms of Huachansu Capsules on Hepatocellular Carcinoma Through Combining Network Pharmacology and Experimental Evaluation. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.00414
|
| 59 |
Laura Soumoy, Ghanem E. Ghanem, Sven Saussez, Fabrice Journe. Bufalin for an innovative therapeutic approach against cancer. Pharmacological Research 2022; 184: 106442 doi: 10.1016/j.phrs.2022.106442
|
| 60 |
Jinhao Jia, Jie Li, Qiusheng Zheng, Defang Li. A research update on the antitumor effects of active components of Chinese medicine ChanSu. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.1014637
|
| 61 |
Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 2009; 18(2) doi: 10.1002/pds.1645
|
| 62 |
Xiyuan Ba, Jiali Wang, Shiyang Zhou, Xinxin Luo, Yun Peng, Shimin Yang, Yue Hao, Guangyi Jin. Cinobufacini protects against paclitaxel-induced peripheral neuropathic pain and suppresses TRPV1 up-regulation and spinal astrocyte activation in rats. Biomedicine & Pharmacotherapy 2018; 108: 76 doi: 10.1016/j.biopha.2018.09.018
|
| 63 |
Maen Zeino, Malte S. Paulsen, Martin Zehl, Ernst Urban, Brigitte Kopp, Thomas Efferth. Identification of new P-glycoprotein inhibitors derived from cardiotonic steroids. Biochemical Pharmacology 2015; 93(1): 11 doi: 10.1016/j.bcp.2014.10.009
|
| 64 |
Zhili Shen, Yan Li, Chengcheng Zhao, Fen Wang, Rongping Zhou, Gang Chen. miR‑494‑BAG‑1 axis is involved in cinobufacini‑induced cell proliferation and apoptosis in gastric cancer. Molecular Medicine Reports 2018; doi: 10.3892/mmr.2018.8788
|
| 65 |
David de Semir, Vladimir Bezrookove, Mehdi Nosrati, Altaf A. Dar, James R. Miller, Stanley P. Leong, Kevin B. Kim, Wilson Liao, Liliana Soroceanu, Sean McAllister, Robert J. Debs, Dirk Schadendorf, Sancy A. Leachman, James E. Cleaver, Mohammed Kashani-Sabet. Nuclear Receptor Coactivator NCOA3 Regulates UV Radiation–Induced DNA Damage and Melanoma Susceptibility. Cancer Research 2021; 81(11): 2956 doi: 10.1158/0008-5472.CAN-20-3450
|
| 66 |
Li-Juan Deng, Yu-He Lei, Jing-Yu Quan, Bao-Jing Li, Dong-Mei Zhang, Hai-Yan Tian, Ye Chen, En-Xin Zhang, Lei Chen, Wen-Cai Ye, Wei-Min Ning, Lin-Zhong Yu, Jun-Shan Liu. 1β–OH–arenobufagin induces mitochondrial apoptosis in hepatocellular carcinoma through the suppression of mTOR signaling pathway. Journal of Ethnopharmacology 2021; 266: 113443 doi: 10.1016/j.jep.2020.113443
|
| 67 |
Chien-shan Cheng, Jiaqiang Wang, Jie Chen, Kuei Ting Kuo, Jian Tang, Huifeng Gao, Lianyu Chen, Zhen Chen, Zhiqiang Meng. New therapeutic aspects of steroidal cardiac glycosides: the anticancer properties of Huachansu and its main active constituent Bufalin. Cancer Cell International 2019; 19(1) doi: 10.1186/s12935-019-0806-1
|
| 68 |
Qingxi Yue, Hong Zhen, Ming Huang, Xi Zheng, Lixing Feng, Baohong Jiang, Min Yang, Wanying Wu, Xuan Liu, Dean Guo, Luis Eduardo M Quintas. Proteasome Inhibition Contributed to the Cytotoxicity of Arenobufagin after Its Binding with Na, K-ATPase in Human Cervical Carcinoma HeLa Cells. PLOS ONE 2016; 11(7): e0159034 doi: 10.1371/journal.pone.0159034
|
| 69 |
Rui-Fang Xie, Zhi-Cheng Li, Bo Gao, Zhi-Na Shi, Xin Zhou. Bufothionine, a possible effective component in cinobufocini injection for hepatocellular carcinoma. Journal of Ethnopharmacology 2012; 141(2): 692 doi: 10.1016/j.jep.2011.12.018
|
| 70 |
Junyu Wu, Guoyi Tang, Chien-Shan Cheng, Ranna Yeerken, Yau-Tuen Chan, Zhiwen Fu, Yi-Chao Zheng, Yibin Feng, Ning Wang. Traditional Chinese medicine for the treatment of cancers of hepatobiliary system: from clinical evidence to drug discovery. Molecular Cancer 2024; 23(1) doi: 10.1186/s12943-024-02136-2
|
| 71 |
Louis Boafo Kwantwi, Theophilus Tandoh. Focal adhesion kinase-mediated interaction between tumor and immune cells in the tumor microenvironment: implications for cancer-associated therapies and tumor progression. Clinical and Translational Oncology 2024; doi: 10.1007/s12094-024-03723-x
|
| 72 |
Alexander A. Azizi, Angela Lamarca, Mairéad G. McNamara, Juan W. Valle. Chemotherapy for advanced gallbladder cancer (GBC): A systematic review and meta-analysis. Critical Reviews in Oncology/Hematology 2021; 163: 103328 doi: 10.1016/j.critrevonc.2021.103328
|
| 73 |
EKEM T. EFUET, XIAO-PING DING, CARRIE CARTWRIGHT, YONG PAN, LORENZO COHEN, PEIYING YANG. Huachansu mediates cell death in non-Hodgkin’s lymphoma by induction of caspase-3 and inhibition of MAP kinase. International Journal of Oncology 2015; 47(2): 592 doi: 10.3892/ijo.2015.3044
|
| 74 |
Jie Wang, Chao Chen, Shiying Wang, Yong Zhang, Peihao Yin, Zhongxiang Gao, Jie Xu, Dianxu Feng, Qinsong Zuo, Ronghua Zhao, Teng Chen. Bufalin Inhibits HCT116 Colon Cancer Cells and Its Orthotopic Xenograft Tumor in Mice Model through Genes Related to Apoptotic and PTEN/AKT Pathways. Gastroenterology Research and Practice 2015; 2015: 1 doi: 10.1155/2015/457193
|
| 75 |
Li-Juan Deng, Long-Hai Wang, Cheng-Kang Peng, Yi-Bin Li, Mao-Hua Huang, Min-Feng Chen, Xue-Ping Lei, Ming Qi, Yun Cen, Wen-Cai Ye, Dong-Mei Zhang, Wei-Min Chen. Fibroblast Activation Protein α Activated Tripeptide Bufadienolide Antitumor Prodrug with Reduced Cardiotoxicity. Journal of Medicinal Chemistry 2017; 60(13): 5320 doi: 10.1021/acs.jmedchem.6b01755
|
| 76 |
Jufeng Xia, Yoshinori Inagaki, Jianjun Gao, Fanghua Qi, Peipei Song, Guohua Han, Tatsuo Sawakami, Bo Gao, Chuan Luo, Norihiro Kokudo, Kiyoshi Hasegawa, Yoshihiro Sakamoto, Wei Tang. Combination of Cinobufacini and Doxorubicin Increases Apoptosis of Hepatocellular Carcinoma Cells through the Fas- and Mitochondria-Mediated Pathways. The American Journal of Chinese Medicine 2017; 45(07): 1537 doi: 10.1142/S0192415X17500835
|
| 77 |
Jian-Hua Yin, Xiao-Yan Zhu, Wei-Dong Shi, Lu-Ming Liu. Huachansu injection inhibits metastasis of pancreatic cancer in mice model of human tumor xenograft. BMC Complementary and Alternative Medicine 2014; 14(1) doi: 10.1186/1472-6882-14-483
|
| 78 |
Xiaolu Wei, Nan Si, Yuefei Zhang, Haiyu Zhao, Jian Yang, Hongjie Wang, Lianmei Wang, Linyu Han, Baolin Bian, Tao Lu. Evaluation of Bufadienolides as the Main Antitumor Components in Cinobufacin Injection for Liver and Gastric Cancer Therapy. PLOS ONE 2017; 12(1): e0169141 doi: 10.1371/journal.pone.0169141
|
| 79 |
Yinglu Feng, Yongan Chen, Yongbin Meng, Qingxin Cao, Qun Liu, Changquan Ling, Chen Wang. Bufalin Suppresses Migration and Invasion of Hepatocellular Carcinoma Cells Elicited by Poly (I:C) Therapy. OncoImmunology 2018; 7(5): e1426434 doi: 10.1080/2162402X.2018.1426434
|
| 80 |
Xiao Sun, Tony T.H. Ng, Kathy W.Y. Sham, Lin Zhang, Matthew T.V. Chan, William K.K. Wu, Christopher H.K. Cheng. Bufalin, a Traditional Chinese Medicine Compound, Prevents Tumor Formation in Two Murine Models of Colorectal Cancer. Cancer Prevention Research 2019; 12(10): 653 doi: 10.1158/1940-6207.CAPR-19-0134
|
| 81 |
Jinghui Zhang, Yanjun Hong, Lilong Jiang, Xiaojiao Yi, Yang Chen, Li Liu, Zhongjian Chen, Yongjiang Wu, Zongwei Cai. Global Metabolomic and Lipidomic Analysis Reveal the Synergistic Effect of Bufalin in Combination with Cinobufagin against HepG2 Cells. Journal of Proteome Research 2020; 19(2): 873 doi: 10.1021/acs.jproteome.9b00681
|
| 82 |
YING LIU, LI-YING BAN, XI SU, SHAN GAO, JI-WEI LIU, XIAO-NAN CUI. Effects of cinobufacini injection on cell proliferation and the expression of topoisomerases in human HepG-2 hepatocellular carcinoma cells. Molecular Medicine Reports 2015; 12(1): 1598 doi: 10.3892/mmr.2015.3552
|
| 83 |
Ying Long, Jialong Fan, Naduo Zhou, Jiahao Liang, Chang Xiao, Chunyi Tong, Wei Wang, Bin Liu. Biomimetic Prussian blue nanocomplexes for chemo-photothermal treatment of triple-negative breast cancer by enhancing ICD. Biomaterials 2023; 303: 122369 doi: 10.1016/j.biomaterials.2023.122369
|
| 84 |
Ruhi Dixit, Manoj Pandey, Punam Pandey, V. K. Shukla. Bioeconomy for Sustainable Development. 2020; : 379 doi: 10.1007/978-981-13-9431-7_20
|
| 85 |
Nour Mhaidly, Noura Barake, Anne Trelcat, Fabrice Journe, Sven Saussez, Géraldine Descamps. Bufalin Suppresses Head and Neck Cancer Development by Modulating Immune Responses and Targeting the β-Catenin Signaling Pathway. Cancers 2024; 16(15): 2739 doi: 10.3390/cancers16152739
|
| 86 |
Qi Wu, Qi-mei Chen, Jing-yi Yang, Jia-yu Zhang, Ai-lin Yang. Material basis revelation of anti-hepatoma effect of Huachansu (Cinobufacini) through down-regulation of thymidylate synthase. Chinese Herbal Medicines 2024; doi: 10.1016/j.chmed.2024.04.002
|
| 87 |
Wentao Jia, Jiaying Yuan, Binbin Cheng, Changquan Ling. Targeting tumor-derived exosome-mediated premetastatic niche formation: The metastasis-preventive value of traditional Chinese medicine. Cancer Letters 2023; 567: 216261 doi: 10.1016/j.canlet.2023.216261
|
| 88 |
Wenpan Peng, Yong Xu, Fanchao Feng, Cheng Gu, Zhichao Wang, Di Han, Xianmei Zhou, Hailang He, Juntra Karbwang. Meta-Analysis of Therapy of Cinobufacini Capsule Adjunct with First-Line Platinum-Based Chemotherapy for the Treatment of Advanced NSCLC. Evidence-Based Complementary and Alternative Medicine 2021; 2021: 1 doi: 10.1155/2021/5596415
|
| 89 |
Fanghua Qi, Anyuan Li, Yoshinori Inagaki, Huanli Xu, Dongliang Wang, Xiaoyan Cui, Li Zhang, Norihiro Kokudo, Guanhua Du, Wei Tang. Induction of apoptosis by cinobufacini preparation through mitochondria- and Fas-mediated caspase-dependent pathways in human hepatocellular carcinoma cells. Food and Chemical Toxicology 2012; 50(2): 295 doi: 10.1016/j.fct.2011.10.040
|
| 90 |
Fang Li, Yan Weng, Lihui Wang, Haibing He, Jingyu Yang, Xing Tang. The efficacy and safety of bufadienolides-loaded nanostructured lipid carriers. International Journal of Pharmaceutics 2010; 393(1-2): 204 doi: 10.1016/j.ijpharm.2010.04.005
|
| 91 |
Bufalin Induces Apoptosis of MDA-MB-231 Cell Through Activation of JNK/p53 Pathway. Journal of Cancer Research Updates 2015; 4(2) doi: 10.6000/1929-2279.2015.04.02.1
|
| 92 |
Tianming Gao, Hua Tang, Baohuan Zhou, Dousheng Bai, Shengjie Jin, Chi Zhang, Guoqing Jiang. Can patients with gallbladder adenocarcinoma and liver metastases obtain survival benefit from surgery? A population-based study. Updates in Surgery 2022; 74(4): 1353 doi: 10.1007/s13304-022-01302-9
|
| 93 |
Chuan-Ming Xie, Wood Yee Chan, Sidney Yu, Jun Zhao, Christopher H.K. Cheng. Bufalin induces autophagy-mediated cell death in human colon cancer cells through reactive oxygen species generation and JNK activation. Free Radical Biology and Medicine 2011; 51(7): 1365 doi: 10.1016/j.freeradbiomed.2011.06.016
|
| 94 |
Zhaohui Zhu, Hanlu Wang, Xu Qian, Meiling Xue, Aijun Sun, Yifei Yin, Jinhai Tang, Jian Zhang. Inhibitory Impact Of Cinobufagin In Triple-Negative Breast Cancer Metastasis: Involvements Of Macrophage Reprogramming Through Upregulated MME and Inactivated FAK/STAT3 Signaling. Clinical Breast Cancer 2024; doi: 10.1016/j.clbc.2024.01.014
|
| 95 |
Shin-Hwar Wu, Yung-Ting Hsiao, Chao-Lin Kuo, Fu-Shun Yu, Shu-Chun Hsu, Ping-Ping Wu, Jaw-Chyun Chen, Te-Chun Hsia, Hsin-Chung Liu, Wu-Huei Hsu, Jing-Gung Chung. Bufalin Inhibits NCI-H460 Human Lung Cancer Cell MetastasisIn Vitroby Inhibiting MAPKs, MMPs, and NF-κB Pathways. The American Journal of Chinese Medicine 2015; 43(06): 1247 doi: 10.1142/S0192415X15500718
|
| 96 |
Lívia Queiroz de Sousa, Kátia da Conceição Machado, Samara Ferreira de Carvalho Oliveira, Lidiane da Silva Araújo, Evaldo dos Santos Monção-Filho, Ana Amélia de Carvalho Melo-Cavalcante, Gerardo Magela Vieira-Júnior, Paulo Michel Pinheiro Ferreira. Bufadienolides from amphibians: A promising source of anticancer prototypes for radical innovation, apoptosis triggering and Na+/K+-ATPase inhibition. Toxicon 2017; 127: 63 doi: 10.1016/j.toxicon.2017.01.004
|
| 97 |
Xu Deng, Jiexia Sheng, Hua Liu, Nannan Wang, Cuoji Dai, Zhenguo Wang, Jing Zhang, Jianye Zhao, Erqing Dai. Cinobufagin Promotes Cell Cycle Arrest and Apoptosis to Block Human Esophageal Squamous Cell Carcinoma Cells Growth <i>via</i> the p73 Signalling Pathway. Biological and Pharmaceutical Bulletin 2019; 42(9): 1500 doi: 10.1248/bpb.b19-00174
|
| 98 |
Ning Tang, Lei Shi, Zhenlong Yu, Peipei Dong, Chao Wang, Xiaokui Huo, Baojing Zhang, Shanshan Huang, Sa Deng, Kexin Liu, Tonghui Ma, Xiaobo Wang, Lijun Wu, Xiao-Chi Ma. Gamabufotalin, a major derivative of bufadienolide, inhibits VEGF-induced angiogenesis by suppressing VEGFR-2 signaling pathway. Oncotarget 2016; 7(3): 3533 doi: 10.18632/oncotarget.6514
|
| 99 |
Paulus S. Wang, Jiun-Yih Yeh, Ching-Han Yu, Shyi-Wu Wang. Evidence-based Anticancer Materia Medica. Evidence-based Anticancer Complementary and Alternative Medicine 2011; : 389 doi: 10.1007/978-94-007-0526-5_18
|
| 100 |
CHUNJIAO LIU, QINHONG KONG, FENG PAN, SHAN JIANG, LINGJIE MENG, GAI HUANG, LIDAN LU, SANHUA LI, YUN LIU. Hellebrigenin induces apoptosis in colorectal cancer Cells through induction of excessive reactive oxygen species. BIOCELL 2021; 45(4): 943 doi: 10.32604/biocell.2021.015836
|
| 101 |
Zhen Yang, Yang Teng, Hao Wang, Huimin Hou. Enhancement of skin permeation of bufalin by limonene via reservoir type transdermal patch: Formulation design and biopharmaceutical evaluation. International Journal of Pharmaceutics 2013; 447(1-2): 231 doi: 10.1016/j.ijpharm.2013.02.048
|